Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT 1A Agonist, in Patients With Parkinson Disease Psychosis: A Pilot Study.

Stuart H IsaacsonMark GoldsteinRajesh PahwaCarlos SingerKevin KlosMichael PucciYi ZhangDavid CrandallKenneth S KoblanBradford Navianull null

Published in: Neurology. Clinical practice (2023)

This Class II study was an exploratory pilot study that was underpowered to detect a statistically significant difference between ulotaront and placebo in the treatment of patients with Parkinson disease psychosis without worsening motor function.

Keyphrases

parkinson disease
deep brain stimulation
heavy metals
randomized controlled trial
double blind
risk assessment
phase iii